Current Neuropharmacology
Title:Erratum:
Volume: 13 Issue: 4
Export Options
About this article
Cite this article as:
Erratum:, Current Neuropharmacology 2015; 13 (4) . https://dx.doi.org/10.2174/1570159X1304150831121355
DOI https://dx.doi.org/10.2174/1570159X1304150831121355 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
31
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
First Phase Insulin Secretion and Type 2 Diabetes
Current Molecular Medicine Enhanced Oral Bioavailability of Oleanolic Acid in Rats with Phospholipid Complex
Letters in Drug Design & Discovery Far-infrared Ray-mediated Antioxidant Potentials are Important for Attenuating Psychotoxic Disorders
Current Neuropharmacology Telomerase Inhibition and Cancer: Might Platinum Based Drugs have a Future as Anti-telomerase Pharmacological Approach?
Current Medicinal Chemistry MicroRNAs and Cardiac Conduction
Current Drug Targets Agonists of the Tissue-Protective Erythropoietin Receptor in the Treatment of Parkinson’s Disease
Current Topics in Medicinal Chemistry Recent Evidence Regarding a Role for Cdk5 Dysregulation in Alzheimers Disease
Current Alzheimer Research Imidazoles as Potential Antifungal Agents: A Review
Mini-Reviews in Medicinal Chemistry 2-Acetylbenzofurans: Synthesis, Reactions and Applications
Current Organic Chemistry Depression as an Immunometabolic Disorder: Exploring Shared Pharmacotherapeutics with Cardiovascular Disease
Current Neuropharmacology Hypertension and Concurrent Arrhythmias
Current Pharmaceutical Design Classification of Sarcomas Using Bioinformatics and Molecular Profiling
Current Pharmaceutical Biotechnology Raf Inhibitors as Therapeutic Agents Against Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Cannabinoid Function in Spatial Learning: An Update
Current Neuropharmacology Structure – Function Relationships of Pre-Fibrillar Protein Assemblies in Alzheimers Disease and Related Disorders
Current Alzheimer Research Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders
CNS & Neurological Disorders - Drug Targets Therapeutic Potential of Alkaloids as Anti-Bacterial Agents: Drugs of Future
Current Bioactive Compounds Structure-Based Rationale for Interleukin 5 Receptor Antagonism
Current Pharmaceutical Design Bacterial Inclusion Bodies for Anti-Amyloid Drug Discovery: Current and Future Screening Methods
Current Protein & Peptide Science Anionic Linear Globular Dendrimer-G2-Ciprofloxacin Nano-Conjugate: Novel Agent against Wilson Disease Cell Model
Letters in Drug Design & Discovery